Clinical Trial

CAYA Cancer Prospective Cohort Study

Recruiting
View on ClinicalTrials.gov →
Summary
Cancer is a leading cause of illness and death among children, adolescents, and young adults(CAYAs), especially in low- and middle-income countries(LMICs), where access to timely diagnosis and treatment is often limited. As a result, patients in these settings may experience higher rates of treatment complications, interruptions, and poorer outcomes compared with those in high-income countries (HICs). This is a prospective, multicenter observational study that will follow children, adolescents, and young adults(CAYAs) with cancer who are receiving routine care at participating hospitals in low - and middle - income countries(LMICs). The study does not involve experimental treatments or changes to standard medical care. Information will be collected from medical records and from questionnaires that address access to care and social factors affecting treatment. By describing treatment outcomes and the challenges patients and families face during cancer care, this study aims to provide data that can help inform future efforts to improve access to care and cancer outcomes in resource-limited settings.
Trial Details
NCT Number NCT07632014
Lead Sponsor Resonance, Inc.
Collaborators: Servier Affaires Médicales
Conditions Cancer, Pediatric Cancer, Lymphoblastic Lymphoma (LBL), Acute Lymphoblastic Leukemia (ALL)
Enrollment 6,000 participants
Start Date 2025-11-11
Primary Completion 2032-11-11 (estimated)
Study Completion 2032-11-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-08